UCB
€205.10Change from previous close: −0.82%Absolute change: −€1.70
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 7,741 | 6,152 | 5,252 | 5,517 |
| Cost of revenue | 1,990 | 1,752 | 1,707 | 1,675 |
| Gross profit | 5,751 | 4,400 | 3,545 | 3,842 |
| Selling, general and administrative | 2,749 | 2,347 | 1,824 | 1,714 |
| Research and development | 1,822 | 1,781 | 1,630 | 1,670 |
| Operating income | 2,004 | 846 | 633 | 701 |
| EBIT | 1,950 | 1,322 | 585 | 582 |
| EBITDA | 2,577 | 1,963 | 1,276 | 1,171 |
| Interest expense | 128 | 159 | 144 | 71.0 |
| Pre-tax income | 1,822 | 1,163 | 441 | 511 |
| Income tax | 264 | 98.0 | 98.0 | 91.0 |
| Net income | 1,558 | 1,065 | 343 | 418 |
| Net income to common shareholders | 1,558 | 1,065 | 343 | 418 |
| Basic EPS | 8.20 | 5.61 | 1.81 | 2.20 |
| Diluted EPS | 8.03 | 5.48 | 1.76 | 2.14 |
| Average shares (basic) | 190 | 190 | 190 | 190 |
| Average shares (diluted) | 194 | 195 | 195 | 195 |